1115 GMT - Strong results for Bayer's crop science segment helped offset a guidance cut for its consumer-health unit, JPMorgan analysts write in a note. A decline in the costs of goods sold, improved spending efficiencies and lower-than-expected reconciliation costs also supported the generally strong third quarter, the bank says. The German healthcare-and-agriculture company's significant exposure to challenging markets in the U.S. and China undercut consumer-health performance and contributed to the weaker outlook, Chief Financial Officer Wolfgang Nickl said in a call following the results. Shares rise 4.5% to trade at 28.67 euros. (william.gray@wsj.com)
(END) Dow Jones Newswires
November 12, 2025 06:15 ET (11:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments